ClinConnect ClinConnect Logo
Search / Trial NCT06775639

Should we Avoid Performing Invasive Coronary Angiography Before Cardiac Surgery in ACHD Patients?

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 9, 2025

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to find out if a less invasive test called Coronary Computer Tomography (CCT) can be enough to check for heart problems in adults with congenital heart disease who need heart surgery. Traditionally, doctors use a method called Invasive Coronary Angiography (ICA), which involves inserting a tube into the blood vessels, but this study aims to see if CCT alone can safely and accurately identify issues like narrowed blood vessels before surgery.

To join this study, participants must be adults with congenital heart disease who are scheduled for heart surgery and have undergone both CCT and ICA tests within the last year. They should be at least 18 years old and able to give their written consent. This research is currently recruiting participants, and those who join can expect to help in determining the best pre-surgery testing methods for people with similar heart conditions. It's important for potential participants to know that certain health issues may prevent them from taking part, such as severe kidney failure or a history of stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult congenital heart disease patient who is a candidate for cardiac surgery for correction of defect valve, or who performed the surgery after 01.01.2010
  • Clinical indication for preoperative ICA and CCT performed less than 12 months apart within 12 months of planned cardiac surgery
  • Age ≥ 18 years
  • Obtaining written informed consent
  • Exclusion Criteria:
  • Inability to perform ICA for any reason (e.g., poor vascular access or anatomical difficulty in reaching the coronary arteries)
  • Patient with severe renal failure on dialysis therapy
  • Patient with previous cerebri stroke

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Gabriele Egidy Assenza, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported